A clinicopathologic study of resected cases of adenosquamous carcinoma of the lung
- PMID: 8635382
- DOI: 10.1378/chest.109.4.989
A clinicopathologic study of resected cases of adenosquamous carcinoma of the lung
Abstract
Adenosquamous carcinoma of the lung is an uncommon form of the lung cancer. Owing to the infrequent occurrence of this disease, no series reported to date (and to our knowledge) has been of adequate size for definitive statistical analysis. In this study, survival curves and background factors affecting prognosis in those with resected adenosquamous carcinoma of the lung were reviewed. In the period from 1973 to 1994, a total of 1,284 patients with primary lung cancer, including 44 cases (3.4%) of adenosquamous carcinoma, were surgically treated in our department. The cumulative 5-year postoperative survival rate, for all cases of adenosquamous carcinoma of the lung was 18.5%. When the survival rates were compared by histologic type, the outcomes of patients with adenosquamous carcinoma were statistically worse than for patients with squamous cell carcinoma and adenocarcinoma, owing to the highly aggressive pathologic stage of adenosquamous carcinoma. The background factors most closely associated with the survival rate in those with adenosquamous carcinoma, using Cox's proportional hazard model, were gender and the degree of nodal involvement. Five-year survival was obtained in seven patients as follows: T1N0M0 in one patient, T2N0M0 in three, T2N1M0 in two, and T3N0M0 in one. Of these seven patients, all had received complete resections, and five were N0 cases. Although our series is small, this study suggest that adenosquamous carcinoma of the lung is an aggressive tumor that grows rapidly.
Similar articles
-
A clinicopathologic study of the resected cases of adenosquamous carcinoma of the lung.Oncol Rep. 1998 Jul-Aug;5(4):861-5. doi: 10.3892/or.5.4.861. Oncol Rep. 1998. PMID: 9625833 Clinical Trial.
-
Adenosquamous carcinoma of the lung. Surgical results compared with squamous cell and adenocarcinoma.Scand Cardiovasc J. 1999;33(1):29-32. doi: 10.1080/14017439950142000. Scand Cardiovasc J. 1999. PMID: 10093856
-
Poor prognosis after lung resection for patients with adenosquamous carcinoma of the lung.Ann Thorac Surg. 2003 Jun;75(6):1740-4. doi: 10.1016/s0003-4975(03)00022-5. Ann Thorac Surg. 2003. PMID: 12822609
-
Adenosquamous carcinoma of the stomach and review of the literature.Pathol Oncol Res. 2015 Jul;21(3):547-51. doi: 10.1007/s12253-014-9890-7. Epub 2015 Jan 8. Pathol Oncol Res. 2015. PMID: 25567665 Review.
-
A clinicopathologic study of primary adenosquamous carcinoma of the liver.J Clin Gastroenterol. 2005 Jul;39(6):544-8. doi: 10.1097/01.mcg.0000165705.74079.fc. J Clin Gastroenterol. 2005. PMID: 15942444 Review.
Cited by
-
Hypercalcemia-Leukocytosis syndrome and adenosquamous lung carcinoma: An overlooked conjugation.Oncol Res. 2022 Jul 13;29(2):81-85. doi: 10.32604/or.2022.023450. eCollection 2021. Oncol Res. 2022. PMID: 37305400 Free PMC article.
-
Surgical Options for Resectable Lung Adenosquamous Carcinoma: A Propensity Score-Matched Analysis.Front Oncol. 2022 Jul 1;12:878419. doi: 10.3389/fonc.2022.878419. eCollection 2022. Front Oncol. 2022. PMID: 35847913 Free PMC article.
-
Prognostic factors of T2aN0M0 (T3-4cmN0M0, stage IB) non-small-cell lung cancer after surgery: Single-center real-world research.Thorac Cancer. 2021 Dec;12(24):3319-3326. doi: 10.1111/1759-7714.14204. Epub 2021 Nov 3. Thorac Cancer. 2021. PMID: 34734467 Free PMC article.
-
Treatment for Patients With Early Stage Adenosquamous Lung Cancer.JTO Clin Res Rep. 2020 Mar 4;1(2):100021. doi: 10.1016/j.jtocrr.2020.100021. eCollection 2020 Jun. JTO Clin Res Rep. 2020. PMID: 34589928 Free PMC article.
-
A nomogram to predict prognosis of patients with lung adenosquamous carcinoma: a population-based study.J Thorac Dis. 2020 May;12(5):2288-2303. doi: 10.21037/jtd.2020.03.115. J Thorac Dis. 2020. PMID: 32642134 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical